title: Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.
authors.affiliation: Centre Hospitalier Universitaire Vaudois, Oncology Department, CHUV BH06, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
authors.forename: Solange
authors.initials: S
authors.lastname: Peters
authors.forename: Olivier
authors.initials: O
authors.lastname: Michielin
authors.forename: Stefan
authors.initials: S
authors.lastname: Zimmermann
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D000077192:Adenocarcinoma of Lung; D000368:Aged; D001707:Biopsy, Needle; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D007211:Indoles / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D008297:Male; D064847:Multimodal Imaging / Q000379:methods; D009154:Mutation; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods; D016133:Polymerase Chain Reaction; D049268:Positron-Emission Tomography; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D013449:Sulfonamides / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf